A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating Women With Uterine Fibroids

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2003
The objective of this study is to determine the safety and efficacy effects of two doses of asoprisnil (10 mg and 25 mg) compared with placebo when administered daily for 6 months to premenopausal subjects with symptomatic uterine leiomyomata.
Epistemonikos ID: e8576390ae67ee53266f3e87d90e3a8c661f504f
First added on: May 04, 2024